SECO USA is donating multiple ventilators to US hospitals, with priority given to Black communities, as the Covid-19 crisis continues.
Biorespira is a non-invasive pulmonary ventilator that delivers oxygen to patients with difficulty breathing in a closed loop system, easily operated by nurses and in-home care providers.
By prioritising the donation of Biorespira Pulmonary Ventilators to facilities in Black communities, SECO USA, a subsidiary of SECO SpA, hopes to reach people who too often have to wait for the most effective healthcare in times of crisis.
Biorespira provides healthcare providers with a device designed to oxygenate adult patients without intubation in almost any location – outside of an ICU, in hospitals’ general medical wards, nursing homes or private residences.
Due to the clarity and simplicity of the interface, nurses, in-home care providers and family members require only minimal training to operate Biorespira.
Biorespira was created as a high-flow system, providing an adjustable percentage of oxygen from 21% to 100% and a flow rate between 10 to 120 L/min.
Using medical helmets or a non-vented face mask with Biorespira ensures a closed loop system, nearly eliminating the chance of the SARS-CoV-2 virus that causes Covid-19 passing from patient to caregiver.
Driven by the desperate need for ventilators during the early stages of the Covid-19 epidemic in Italy, Italian Biomedical Devices (IBD), a local technology company led by Dr. Corrado Ghidini, quickly created the non-invasive and portable ventilator, going from concept design to first prototype build in just five weeks.
An existing relationship with SECO SpA evolved to include the distribution of Biorespira worldwide.
“Doctors around the world agree that assisted lung ventilation is the only effective therapy for patients with Covid-19 pneumonia with ventilatory impairment,” explained Dr. Ghidini.
“I’m eager to see Biorespira deployed and helping patients fight the effects of pneumonia and respiratory insufficiencies around the world, especially in communities that face challenges in receiving top-quality healthcare.”
“At SECO USA, we feel it is vital to make the life-saving capabilities of Biorespira available to people in Black communities in the US,” said Greg Nicoloso, CEO for SECO USA.
“SECO USA has partnered with IBD to bring the Biorespira Pulmonary Ventilator to the U.S. market – our goal with this donation program is to deliver this vital capability to under-resourced hotspots in time to reduce deaths from Covid-19.”